COM:AERIEPHARMA
Aerie Pharmaceuticals, Inc.
- Stock
Last Close
15.25
18/11 21:00
Volume Today
1.22M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 5.06M - | 15.58M 208.21% | 24.06M 54.38% | 33.73M 40.23% | ||||||
average payables | 808K - | 1.75M 117.20% | 1.85M 5.33% | 3.62M 95.81% | 5.93M 63.77% | 9.32M 57.30% | 12.59M 34.99% | 10.80M 14.21% | 8.56M 20.77% | |
average receivables | 1.36M - | 20.53M 1,412.67% | 47.19M 129.80% | 107.42M 127.65% | ||||||
book value per share | 13.51 - | 1.16 91.39% | 0.73 37.45% | 3.62 396.49% | 3.84 6.17% | 5.47 42.44% | 3.68 32.78% | 0.52 85.79% | -0.37 171.63% | |
capex per share | -0.01 - | -0.01 40.89% | -0.13 1,593.04% | -0.17 36.97% | -0.45 159.45% | -0.75 66.24% | -0.22 70.83% | -0.07 69.19% | -0.07 5.16% | |
capex to depreciation | -0.98 - | -2.48 151.88% | -13.02 424.95% | -5.23 59.79% | -11.33 116.40% | -12.82 13.21% | -0.55 95.71% | -0.09 83.49% | -0.09 3.30% | |
capex to operating cash flow | 0.00 - | 0.01 40.12% | 0.06 996.34% | 0.06 8.08% | 0.17 169.43% | 0.21 19.79% | 0.07 67.74% | 0.05 27.61% | 0.03 30.74% | |
capex to revenue | -1.29 - | -0.14 89.00% | -0.04 73.83% | -0.02 54.54% | ||||||
cash per share | 14.05 - | 5.81 58.67% | 5.30 8.82% | 8.02 51.40% | 7.07 11.87% | 4.87 31.12% | 6.81 39.82% | 5.24 23.06% | 3.02 42.39% | |
days of inventory on hand | 5.76K - | 1.59K 72.39% | 389.87 75.48% | 549.42 40.92% | ||||||
days payables outstanding | 7.06K - | 964.42 86.34% | 127.17 86.81% | 112.64 11.42% | ||||||
days sales outstanding | 40.98 - | 200.31 388.78% | 245.95 22.79% | 298.62 21.41% | ||||||
debt to assets | 0.05 - | 0.83 1,571.24% | 0.88 6.79% | 0.58 34.73% | 0.53 7.43% | 0.20 62.32% | 0.63 214.31% | 0.94 49.00% | 1.04 10.61% | |
debt to equity | 0.05 - | 4.74 9,025.85% | 7.48 57.56% | 1.36 81.85% | 1.14 15.92% | 0.25 77.97% | 1.71 580.99% | 15.77 821.91% | -25.89 264.12% | |
dividend yield | ||||||||||
earnings yield | -0.35 - | -0.07 80.44% | -0.12 73.03% | -0.09 24.17% | -0.07 23.46% | -0.15 124.91% | -0.18 17.56% | -0.30 62.45% | -0.23 22.12% | |
enterprise value | 19.36M - | 741.66M 3,731.59% | 659.95M 11.02% | 1.03B 55.83% | 2.04B 98.07% | 1.30B 36.12% | 1.15B 11.76% | 683.80M 40.45% | 548.74M 19.75% | |
enterprise value over ebitda | -0.71 - | -15.64 2,104.42% | -9.23 40.95% | -10.78 16.80% | -14.24 32.00% | -5.72 59.84% | -6.90 20.76% | -5.83 15.51% | -70.23 1,104.00% | |
ev to operating cash flow | -1.18 - | -21.99 1,768.65% | -11.84 46.17% | -12.88 8.80% | -21.85 69.65% | -8.53 60.97% | -7.63 10.50% | -10.57 38.49% | -5.53 47.64% | |
ev to sales | 53.81 - | 16.43 69.47% | 8.22 49.94% | 2.83 65.63% | ||||||
free cash flow per share | -3.33 - | -1.41 57.75% | -2.29 62.64% | -2.91 27.30% | -3.09 6.05% | -4.41 42.80% | -3.53 20.01% | -1.48 58.17% | -2.21 49.69% | |
free cash flow yield | -0.19 - | -0.05 74.00% | -0.09 94.97% | -0.08 18.10% | -0.05 32.82% | -0.12 136.35% | -0.15 19.48% | -0.11 25.16% | -0.31 188.08% | |
graham net net | 13.35 - | 0.29 97.86% | -0.15 151.45% | 3.11 2,218.83% | 2.69 13.68% | 3.66 36.29% | 1.38 62.26% | -1.79 229.45% | -3.66 104.45% | |
graham number | 43.72 - | 7.24 83.45% | 6.87 4.98% | 16.63 141.92% | 18.84 13.26% | 26.21 39.12% | 19.06 27.27% | 6.85 64.08% | 3.69 46.16% | |
income quality | 0.53 - | 0.70 32.69% | 0.75 6.99% | 0.81 7.52% | 0.64 20.30% | 0.66 2.13% | 0.75 14.89% | 0.35 53.13% | 1.33 275.15% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -5.84 - | -79.57 1,262.11% | -30.12 62.15% | -38.18 26.78% | -61.53 61.13% | -82.87 34.69% | -12.29 85.17% | -5.88 52.15% | -1.60 72.73% | |
interest debt per share | 0.77 - | 5.18 576.52% | 4.88 5.87% | 4.33 11.27% | 3.57 17.43% | 0.06 98.30% | 4.61 7,488.33% | 5.27 14.27% | 6.25 18.63% | |
inventory turnover | 0.06 - | 0.23 262.13% | 0.94 307.84% | 0.66 29.04% | ||||||
invested capital | 4.43 - | 6.56 48.25% | 1.17 82.13% | 0.91 22.12% | 1.16 - | 8.98 672.41% | -15.04 267.40% | |||
market cap | 89.01M - | 703.09M 689.94% | 627.77M 10.71% | 1.10B 75.67% | 2.11B 91.39% | 1.50B 28.74% | 1.10B 27.00% | 620.07M 43.53% | 325.28M 47.54% | |
net current asset value | 66.78M - | 8.00M 88.02% | -1.93M 124.05% | 94.78M 5,023.64% | 99.47M 4.94% | 162.94M 63.81% | 90.68M 44.34% | -46.32M 151.08% | -93.07M 100.93% | |
net debt to ebitda | 2.55 - | -0.81 131.86% | -0.45 44.64% | 0.78 273.34% | 0.52 33.97% | 0.89 72.95% | -0.30 133.88% | -0.54 80.05% | -28.60 5,160.98% | |
net income per share | -6.29 - | -2.00 68.21% | -2.88 44.34% | -3.40 17.87% | -4.11 20.82% | -5.58 35.89% | -4.39 21.29% | -3.99 9.20% | -1.61 59.53% | |
operating cash flow per share | -3.32 - | -1.40 57.81% | -2.16 54.43% | -2.74 26.73% | -2.64 3.70% | -3.66 38.78% | -3.31 9.57% | -1.41 57.44% | -2.14 51.82% | |
payables turnover | 0.05 - | 0.38 632.31% | 2.87 658.40% | 3.24 12.89% | ||||||
receivables turnover | 8.91 - | 1.82 79.54% | 1.48 18.56% | 1.22 17.64% | ||||||
research and ddevelopement to revenue | 3.56 - | 1.31 63.29% | 0.89 31.92% | 0.39 56.12% | ||||||
return on tangible assets | -0.44 - | -0.30 32.41% | -0.47 56.40% | -0.40 14.61% | -0.50 25.28% | -0.82 63.22% | -0.44 45.95% | -0.46 3.28% | -0.17 61.92% | |
revenue per share | 0.58 - | 1.54 165.08% | 1.81 17.74% | 4.19 131.30% | ||||||
roe | -0.47 - | -1.72 269.08% | -3.96 130.75% | -0.94 76.26% | -1.07 13.80% | -1.02 4.60% | -1.20 17.10% | -7.64 539.04% | 4.32 156.50% | |
roic | 0.32 - | 4.11 1,203.32% | 3.06 25.69% | 0.63 79.27% | 1.30 104.56% | 1.58 21.73% | -1.23 178.20% | -1.78 44.28% | -0.13 92.47% | |
sales general and administrative to revenue | 4.99 - | 1.98 60.30% | 1.65 16.68% | |||||||
shareholders equity per share | 13.51 - | 1.16 91.39% | 0.73 37.45% | 3.62 396.49% | 3.84 6.17% | 5.47 42.44% | 3.68 32.78% | 0.52 85.79% | -0.37 171.63% | |
stock based compensation to revenue | 1.60 - | 0.65 59.71% | 0.48 25.25% | 0.15 68.47% | ||||||
tangible asset value | 66.98M - | 28.04M 58.13% | 18.77M 33.05% | 105.34M 461.09% | 135.60M 28.72% | 227.81M 68.00% | 166.95M 26.71% | 23.97M 85.64% | -17.33M 172.32% | |
tangible book value per share | 13.51 - | 1.16 91.39% | 0.73 37.45% | 3.62 396.49% | 3.84 6.17% | 5.47 42.44% | 3.68 32.78% | 0.52 85.79% | -0.37 171.63% | |
working capital | 66.78M - | 132.16M 97.89% | 121.31M 8.21% | 218.32M 79.97% | 228.96M 4.87% | 169.39M 26.02% | 292.69M 72.79% | 227.28M 22.35% | 230.66M 1.49% |
All numbers in (except ratios and percentages)